Coagulation signalling following tissue injury: Focus on the role of factor Xa

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 6-7, 2008, Pages 1228-1237

  Krupiczojc, Malvina A ^a   Scotton, Chris J ^a   Chambers, Rachel C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Coagulation cascade; Fibrosis; Inflammation; Proteinase activated receptor; Tissue injury

Indexed keywords

BLOOD CLOTTING FACTOR 10A; HEPARIN; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 1 ANTAGONIST; WARFARIN;

ARTHRITIS; BLOOD CLOTTING; CLINICAL TRIAL; DRUG MECHANISM; ENZYME REGULATION; FIBROSIS; HEMOSTASIS; HUMAN; KIDNEY DISEASE; LUNG INJURY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; TARGET CELL; THROMBOSIS; TISSUE INJURY; TISSUE REPAIR;

BLOOD COAGULATION; FACTOR XA; FIBROSIS; INFLAMMATION; MODELS, BIOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, PROTEINASE-ACTIVATED; SIGNAL TRANSDUCTION;

EID: 43049113102     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.02.026     Document Type: Review

References (87)

1. Altieri D.C., and Stamnes S.J. Protease-dependent T cell activation: ligation of effector cell protease receptor-1 (EPR-1) stimulates lymphocyte proliferation. Cell Immunol 155 (1994) 372-383
2. Ansell J. Factor Xa or thrombin: is factor Xa a better target?. J Thromb Haemost 5 Suppl. 1 (2007) 60-64
3. Bachli E.B., Pech C.M., Johnson K.M., Johnson D.J., Tuddenham E.G., and McVey J.H. Factor Xa and thrombin, but not factor VIIa, elicit specific cellular responses in dermal fibroblasts. J Thromb Haemost 1 (2003) 1935-1944
4. Bauer K.A. New anticoagulants. Hematol Am Soc Hematol Educ Program (2006) 450-456
5. Bauer K.A. New anticoagulants: anti IIa vs. anti Xa-is one better?. J Thromb Thrombolysis 21 (2006) 67-72
6. Blanc-Brude O.P., Archer F., Leoni P., Derian C., Bolsover S., Laurent G.J., et al. Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation. Exp Cell Res 304 (2005) 16-27
7. Blanc-Brude O.P., Chambers R.C., Leoni P., Dik W.A., and Laurent G.J. Factor Xa is a fibroblast mitogen via binding to effector-cell protease receptor-1 and autocrine release of PDGF. Am J Physiol Cell Physiol 281 (2001) C681-C689
8. Bogatkevich G.S., Gustilo E., Oates J.C., Feghali-Bostwick C., Harley R.A., Silver R.M., et al. Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. AJP: Lung Cell Mol Physiol 288 (2005) L190-L201
9. Camerer E., Kataoka H., Kahn M., Lease K., and Coughlin S.R. Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells. J Biol Chem 277 (2002) 16081-16087
10. Chambers R.C. Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?. Br J Pharmacol 153 (2008) S367-S378
11. Chambers R.C. Role of coagulation cascade proteases in lung repair and fibrosis. Eur Respir J 44 Suppl. (2003) 33s-35s
12. Chambers R.C., and Laurent G.J. Coagulation cascade proteases and tissue fibrosis. Biochem Soc Trans 30 (2002) 194-200
13. Chambers R.C., Leoni P., Blanc-Brude O.P., Wembridge D.E., and Laurent G.J. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem 275 (2000) 35584-35591
14. Cheung W.M., D'Andrea M.R., Andrade-Gordon P., and Damiano B.P. Altered vascular injury responses in mice deficient in protease-activated receptor-1. Arterioscler Thromb Vasc Biol 19 (1999) 3014-3024
15. Cirino G., Cicala C., Bucci M., Sorrentino L., Ambrosini G., DeDominicis G., et al. Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo. J Clin Invest 99 (1997) 2446-2451
16. Coughlin S.R. How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96 (1999) 11023-11027
17. Creasey A.A., Chang A.C., Feigen L., Wun T.C., Taylor Jr. F.B., and Hinshaw L.B. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 91 (1993) 2850-2860
18. Cunningham M.A., Rondeau E., Chen X., Coughlin S.R., Holdsworth S.R., and Tipping P.G. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 191 7 February (3) (2000) 455-462
19. Daubie V., Cauwenberghs S., Senden N.H., Pochet R., Lindhout T., Buurman W.A., et al. Factor Xa and thrombin evoke additive calcium and proinflammatory responses in endothelial cells subjected to coagulation. Biochim Biophys Acta 1763 (2006) 860-869
20. Dewerchin M., Liang Z., Moons L., Carmeliet P., Castellino F.J., Collen D., et al. Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice. Thromb Haemost 83 (2000) 185-190
21. Di Scipio R.G., Hermodson M.A., and Davie E.W. Activation of human factor X (Stuart factor) by a protease from Russell's viper venom. Biochemistry 16 (1977) 5253-5260
22. Feistritzer C., Lenta R., and Riewald M. Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling. J Thromb Haemost 3 (2005) 2798-2805
23. Feistritzer C., and Riewald M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105 (2005) 3178-3184
24. Finigan J.H., Dudek S.M., Singleton P.A., Chiang E.T., Jacobson J.R., Camp S.M., et al. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J Biol Chem 280 (2005) 17286-17293
25. Fiorucci S., Antonelli E., Distrutti E., Severino B., Fiorentina R., Baldoni M., et al. PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation. Hepatology 39 (2004) 365-375
26. Florell S.R., and Rodgers G.M. Inherited thrombotic disorders: an update. Am J Hematol 54 (1997) 53-60
27. Furie B., and Furie B.C. The molecular basis of blood coagulation. Cell 53 (1988) 505-518
28. Gajdusek C., Carbon S., Ross R., Nawroth P., and Stern D. Activation of coagulation releases endothelial cell mitogens. J Cell Biol 103 (1986) 419-428
29. Gasic G.P., Arenas C.P., Gasic T.B., and Gasic G.J. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA 89 (1992) 2317-2320
30. Gui T., Reheman A., Funkhouser W.K., Bellinger D.A., Hagaman J.R., Stafford D.W., et al. In vivo response to vascular injury in the absence of factor IX: examination in factor IX knockout mice. Thromb Res 121 (2007) 225-234
31. Gunther A., Lubke N., Ermert M., Schermuly R.T., Weissmann N., Breithecker A., et al. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. Am J Respir Crit Care Med 168 (2003) 1358-1365
32. Gunther A., Mosavi P., Heinemann S., Ruppert C., Muth H., Markart P., et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 161 (2000) 454-462
33. Herbert J., Bono F., Herault J., Avril C., Dol F., Mares A., et al. Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo. J Clin Invest 101 (1998) 993-1000
34. Hernandez Rodriguez N.A., Cambrey A.D., Harrison N.K., Chambers R.C., Gray A.J., Southcott A.M., et al. Role of thrombin in pulmonary fibrosis. Lancet 346 (1995) 1071-1073
35. Herrmann F.H., Auerswald G., Ruiz-Saez A., Navarrete M., Pollmann H., Lopaciuk S., et al. Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene. Haemophilia 12 (2006) 479-489
36. Ho G., Toomey J.R., Broze Jr. G.J., and Schwartz A.L. Receptor-mediated endocytosis of coagulation factor Xa requires cell surface-bound tissue factor pathway inhibitor. J Biol Chem 271 (1996) 9497-9502
37. Hougie C., Barrow E.M., and Graham J.B. Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency. J Clin Invest 36 (1957) 485-496
38. Howell D.C., Goldsack N.R., Marshall R.P., McAnulty R.J., Starke R., Purdy G., et al. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol 159 (2001) 1383-1395
39. Howell D.C., Johns R.H., Lasky J.A., Shan B., Scotton C.J., Laurent G.J., et al. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am J Pathol 166 (2005) 1353-1365
40. Huang Z.F., Higuchi D., Lasky N., and Broze Jr. G.J. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 90 (1997) 944-951
41. Idell S., Gonzalez K., and Bradford H. Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII. Am Rev Respir Dis 136 (1987) 1466-1474
42. Imamura T., Potempa J., Tanase S., and Travis J. Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. J Biol Chem 272 (1997) 16062-16067
43. Imokawa S., Sato A., Hayakawa H., Kotani M., Urano T., and Takada A. Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis. Am J Respir Crit Care Med 156 (1997) 631-636
44. Jackson C.M. Factor X. Prog Hemost Thromb 7 (1984) 55-109
45. Jenkins R.G., Su X., Su G., Scotton C.J., Camerer E., Laurent G.J., et al. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 116 (2006) 1606-1614
46. Jones A., and Geczy C.L. Thrombin and factor Xa enhance the production of interleukin-1. Immunology 71 (1990) 236-241
47. Kaneider N.C., Leger A.J., Agarwal A., Nguyen N., Perides G., Derian C., et al. 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. Nat Immunol 8 (2007) 1303-1312
48. Kelso E.B., Lockhart J.C., Hembrough T., Dunning L., Plevin R., Hollenberg M.D., et al. Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation. J Pharmacol Exp Ther 316 (2006) 1017-1024
49. Kerschen E.J., Fernandez J.A., Cooley B.C., Yang X.V., Sood R., Mosnier L.O., et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med 204 (2007) 2439-2448
50. Koo B.H., and Kim D.S. Factor Xa induces mitogenesis of vascular smooth muscle cells via autocrine production of epiregulin. J Biol Chem 278 (2003) 52578-52586
51. Kubo H., Nakayama K., Yanai M., Suzuki T., Yamaya M., Watanabe M., et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 128 (2005) 1475-1482
52. Neuenschwander P.F., and Factor X. In: Laurent G., and Shapiro S. (Eds). Encyclopedia of Respiratory Medicine (2007), Academic Press
53. Lawson J.H., Kalafatis M., Stram S., and Mann K.G. A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem 269 (1994) 23357-23366
54. Lindner J.R., Kahn M.L., Coughlin S.R., Sambrano G.R., Schauble E., Bernstein D., et al. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J Immunol 165 (2000) 6504-6510
55. Mann K.G., Brummel K., and Butenas S. What is all that thrombin for?. J Thromb Haemost 1 (2003) 1504-1514
56. Mann K.G., Butenas S., and Brummel K. The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol 23 (2003) 17-25
57. Marshall R.P., Bellingan G., Webb S., Puddicombe A., Goldsack N., McAnulty R.J., et al. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 162 (2000) 1783-1788
58. McLaughlin J.N., Shen L., Holinstat M., Brooks J.D., Dibenedetto E., and Hamm H.E. Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1. J Biol Chem 280 (2005) 25048-25059
59. Monroe D.M., Hoffman M., and Roberts H.R. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 22 (2002) 1381-1389
60. Monroe D.M., and Key N.S. The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking. J Thromb Haemost 5 (2007) 1097-1105
61. Narita M., Rudolph A.E., Miletich J.P., and Schwartz A.L. The low-density lipoprotein receptor-related protein (LRP) mediates clearance of coagulation factor Xa in vivo. Blood 91 (1998) 555-560
62. Nicholson A.C., Nachman R.L., Altieri D.C., Summers B.D., Ruf W., Edgington T.S., et al. Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa. J Biol Chem 271 (1996) 28407-28413
63. Nomura K., Liu N., Nagai K., Hasegawa T., Kobayashi I., Nogaki F., et al. Roles of coagulation pathway and factor Xa in rat mesangioproliferative glomerulonephritis. Lab Invest 87 (2007) 150-160
64. Ohba T., McDonald J.K., Silver R.M., Strange C., LeRoy E.C., and Ludwicka A. Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor. Am J Respir Cell Mol Biol 10 (1994) 405-412
65. Ossovskaya V.S., and Bunnett N.W. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84 (2004) 579-621
66. Papapetropoulos A., Piccardoni P., Cirino G., Bucci M., Sorrentino R., Cicala C., et al. Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling. Proc Natl Acad Sci USA 95 (1998) 4738-4742
67. Pawlinski R., Tencati M., Hampton C.R., Shishido T., Bullard T.A., Casey L.M., et al. Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy. Circulation 116 (2007) 2298-2306
68. Plescia J., and Altieri D.C. Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem J 319 Pt 3 (1996) 873-879
69. Rau J.C., Beaulieu L.M., Huntington J.A., and Church F.C. Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 5 Suppl. 1 (2007) 102-115
70. Riewald M., Kravchenko V.V., Petrovan R.J., O'Brien P.J., Brass L.F., Ulevitch R.J., et al. Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood 97 (2001) 3109-3116
71. Riewald M., Petrovan R.J., Donner A., Mueller B.M., and Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296 (2002) 1880-1882
72. Riewald M., and Ruf W. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling. J Biol Chem 280 (2005) 19808-19814
73. Riewald M., and Ruf W. Orchestration of coagulation protease signaling by tissue factor. Trends Cardiovasc Med 12 (2002) 149-154
74. Ruf W. Is APC activation of endothelial cell PAR1 important in severe sepsis?: Yes. J Thromb Haemost 3 (2005) 1912-1914
75. Senden N.H., Jeunhomme T.M., Heemskerk J.W., Wagenvoord R., van't Veer C., Hemker H.C., et al. Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J Immunol 161 (1998) 4318-4324
76. Siflinger-Birnboim A., and Johnson A. Protein kinase C modulates pulmonary endothelial permeability: a paradigm for acute lung injury. Am J Physiol Lung Cell Mol Physiol 284 (2003) L435-L451
77. Sutherland M.R., Raynor C.M., Leenknegt H., Wright J.F., and Pryzdial E.L. Coagulation initiated on herpesviruses. Proc Natl Acad Sci USA 94 (1997) 13510-13514
78. Takizawa T., Tamiya M., Hara T., Matsumoto J., Saito N., Kanke T., et al. Abrogation of bronchial eosinophilic inflammation and attenuated eotaxin content in protease-activated receptor 2-deficient mice. J Pharmacol Sci 98 (2005) 99-102
79. Tanaka M., Arai H., Liu N., Nogaki F., Nomura K., Kasuno K., et al. Role of coagulation factor Xa and protease-activated receptor 2 in human mesangial cell proliferation. Kidney Int 67 (2005) 2123-2133
80. Taylor Jr. F.B., Chang A.C., Peer G.T., Mather T., Blick K., Catlett R., et al. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood 78 (1991) 364-368
81. van Dieijen G., Tans G., Rosing J., and Hemker H.C. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 256 (1981) 3433-3442
82. Vu T.K., Hung D.T., Wheaton V.I., and Coughlin S.R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64 (1991) 1057-1068
83. Wallin R., and Turner R. Propeptide recognition by the vitamin K-dependent carboxylase in early processing of prothrombin and factor X. Biochem J 272 (1990) 473-478
84. Weiss E.J., Hamilton J.R., Lease K.E., and Coughlin S.R. Protection against thrombosis in mice lacking PAR3. Blood 100 (2002) 3240-3244
85. Weitz J.I. Factor Xa or thrombin: is thrombin a better target?. J Thromb Haemost 5 Suppl. 1 (2007) 65-67
86. Yasui H., Gabazza E.C., Tamaki S., Kobayashi T., Hataji O., Yuda H., et al. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med 163 (2001) 1660-1668
87. Zaman G.J., and Conway E.M. The elusive factor Xa receptor: failure to detect transcripts that correspond to the published sequence of EPR-1. Blood 96 (2000) 145-148